Q32 Bio prices offering including pre-funded warrants at USD 18.2499 each

Q32 Bio priced a $200 million public offering that includes 4,931,506 pre-funded warrants to buy common stock.

• Pre-funded warrants were priced at USD 18.2499 each with a USD 0.0001 per share exercise price; common shares were priced at USD 18.25.
• The offering includes 6,027,399 common shares; underwriters hold a 30-day option for up to 1,643,835 additional shares.
• The deal is expected to close around July 16, 2026; proceeds are earmarked for working capital, including R&D and bempikibart development.